Stille Coupling of Haloallenes and Alkenylstannanes
(s, 3H), 1.87 (dd, J ) 12.4, 4.0, 2.1 Hz, 1H), 1.44 (t, J ) 11.5 Hz,
2H), 1.4-1.3 (m, 1H), 1.36 (s, 3H), 1.30 (s, 3H), 1.10 (s, 3H) ppm;
13C NMR (100 MHz, CDCl3) δ 201.6 (s), 170.4 (s), 119.0 (s), 71.5
(s), 67.5 (d), 44.5 (t, 2×), 38.3 (d), 35.0 (s), 30.8 (q), 30.4 (q),
29.4 (q), 21.2 (q); MS (ESI+) m/z (%) 374 (14), 373 (M+ + 23,
100), 273 (11); HMRS (ESI+) calcd for C13H19INaO3, 373.0271;
found, 373.0264. Anal. Calcd for C13H19IO3: C, 44.59; H, 5.47.
Found: C, 44.62; H, 5.44.
DMF (12 mL). At this point, the reaction mixture was thoroughly
degassed using freeze-thaw cycles (3×) [where required, (iPr)2NEt
(1.5 mmol) was added at this point]. After stirring at 25 °C for the
time period listed in Table 1, an aqueous saturated KF solution
was added, the layers were separated, and the aqueous layer was
extracted with EtOAc (3×). The combined organic layers were
washed with brine (3×) and dried (Na2SO4), and the solvent was
removed. The residue was purified by chromatography on silica
gel to afford the corresponding vinylallene.
1
Data for (1S,3R,4aS)-2b: H NMR (400 MHz, CDCl3) δ 5.84
(s, 1H), 5.28 (m, 1H), 2.19 (ddd, J ) 12.9, 4.2, 2.2 Hz, 1H), 1.98
(s, 3H), 1.89 (ddd, J ) 12.3, 4.1, 2.2 Hz, 1H), 1.4-1.3 (m, 2H),
1.37 (s, 3H), 1.32 (s, 3H), 1.08 (s, 3H) ppm; 13C NMR (100 MHz,
CDCl3) δ 200.7 (s), 170.2 (s), 118.9 (s), 71.2 (s), 67.5 (d), 44.7 (t),
44.5 (t), 38.7 (d), 34.7 (s), 31.9 (q), 30.6 (q), 28.1 (q), 21.2 (q);
MS (ESI+) m/z (%) 374 (13), 373 (M+ + 23, 100), 273 (6); HMRS
(ESI+) calcd for C13H19INaO3, 373.0271; found, 373.0263.
(-)-(1R,3S,6aR)-6-(2-Bromovinylidene)-3-(tert-butyldimethylsi-
lyloxy)-1,5,5-trimethylcyclohexan-1-ol (aR)-8a. CuBr (0.23 g, 1.58
mmol), NH4Br (0.08 g, 0.79 mmol), and HBr (48% aq, 0.29 mL,
2.53 mmol) were added sequentially to a cooled (-10 °C) solution
of tert-butyldimethylsilyl (1R,3S,6R)-6-ethynyl-1,5,5-trimethyl-7-
oxabicyclo[4.1.0]heptan-3-yl ether6b (0.47 g, 1.58 mmol) in Et2O
(7.7 mL). After stirring for 30 min, an aqueous solution of NH4Cl/
NH3 1:1 (10 mL) was added, and the layers were separated. The
organic layer was washed with brine (3×) and dried (Na2SO4), and
the solvent was evaporated. The residue was purified by column
chromatography (silica gel, gradient from 95:5 to 90:10 hexane/
EtOAc) to afford 0.172 g (29%) of a white solid identified as
(1R,3S,6aR)-6-(2-bromovinylidene)-3-(tert-butyldimethylsilyloxy)-
1,5,5-trimethylcyclohexan-1-ol (aR)-8a. A fraction containing
a mixture of products was further purified by HPLC (Nova-Pak
HR, 6 mm, 30 × 1.9 cm, 97:3 hexane/AcOEt, 3 mL/min) to
afford 8.1 mg of the corresponding (1R,3S,6aS)-6-(2-bromovi-
nylidene)-3-(tert-butyldimethylsilyloxy)-1,5,5-trimethylcyclohexan-
1-ol (aS)-8a.
(+)-(1R,5S,2aR)- and (+)-(1R,5S,2aS)-5-(tert-Butyldimethylsi-
lyloxy)-2-[(3E)-5-hydroxypenta-1,3-dienylidene]-1,3,3-trimethylcy-
clohexanol 9. Following the general procedure for the cross-coupling
reaction, the reaction between bromoallene (aR)-8a (0.03 g, 0.08
mmol), stannane 7 (0.04 g, 0.16 mmol), and Pd(PPh3)4 (0.009 g,
0.008 mmol) afforded, after purification by chromatography on
silica gel (70:30 hexane/EtOAc), 0.017 g (60%) of (1R,5S,2aS)-9
1
and 0.008 g (28%) of (1R,5S,2aR)-9. Data for (1R,5S,2aR)-9: H
NMR (400 MHz, CDCl3) δ 6.01 (ddt, J ) 15.1, 10.2, 1.0 Hz, 1H),
5.88 (d, J ) 10.2 Hz, 1H), 5.79 (dt, J ) 15.2, 5.9 Hz, 1H), 4.25
(tt, J ) 11.0, 4.2 Hz, 1H), 4.17 (dd, J ) 5.9, 1.0 Hz, 2H), 2.10
(ddd, J ) 13.1, 4.1, 2.2 Hz, 1H), 1.78 (ddd, J ) 12.6, 4.1, 2.1 Hz,
1H), 1.59 (br s, 2H), 1.42 (dd, J ) 13.1, 10.9 Hz, 1H), 1.33 (s,
3H), 1.31 (dd, J ) 13.6, 10.4 Hz, 1H), 1.29 (s, 3H), 1.03 (s, 3H),
0.89 (s, 9H), 0.90 (s, 6H) ppm; 13C NMR (100 MHz, CDCl3) δ
203.5 (s), 129.6 (d), 127.6 (d), 116.4 (s), 96.3 (d), 72.8 (s), 64.8
(d), 63.4 (t), 49.7 (t), 49.1 (t), 35.5 (s), 32.1 (q), 31.2 (q), 29.2 (q),
25.9 (q, 3×), 18.2 (s), -4.6 (q, 2×) ppm; MS (ESI+) 375 ([M +
Na]+, 100); HRMS (ESI+) calcd for C20H36NaO3Si, 375.2326;
found, 375.2323; IR (NaCl) ν 3600-3100 (br, OH), 2956 (s, C-H),
2927 (s, C-H), 1939 (w, CdCdC); [R]22D +86.0 (c 0.02, MeOH).
1
Data for (1R,5S,2aS)-9: H NMR (400 MHz, CDCl3) δ 6.07 (ddt,
J ) 14.8, 10.4, 1.0 Hz, 1H), 6.00 (d, J ) 10.4 Hz, 1H), 5.80 (dt,
J ) 14.8, 5.8 Hz, 1H), 4.25 (tt, J ) 11.1, 4.2 Hz, 1H), 4.18 (dd, J
) 5.8, 1.0 Hz, 2H), 2.08 (ddd, J ) 13.1, 4.2, 1.8 Hz, 1H), 1.75
(ddd, J ) 12.6, 4.1, 2.1 Hz, 1H), 1.71-1.54 (br s, 1H), 1.38 (dd,
J ) 13.1, 10.9 Hz, 1H), 1.32 (s, 3H), 1.31 (s, 3H), 1.32-1.30 (m,
1H), 1.03 (s, 3H), 0.89 (s, 9H), 0.08 (s, 6H) ppm; 13C NMR (100
MHz, CDCl3) δ 203.2 (s), 129.9 (d), 127.8 (d), 116.4 (s), 96.6 (d),
72.9 (s), 64.8 (d), 63.3 (t), 49.5 (t), 48.9 (t), 35.3 (s), 32.0 (q), 31.2
(q), 29.9 (q), 25.9 (q, 3×), 18.1 (s), -4.6 (q, 2×) ppm; MS (ESI+)
375 ([M + Na]+, 100); HRMS (ESI+) calcd for C20H36NaO3Si,
375.2326; found, 375.2324; IR (NaCl) ν 3600-3100 (br, OH), 2956
1
Data for (aR)-8a: H NMR (400 MHz, CDCl3) δ 5.92 (s, 1H),
4.21 (m, 1H), 2.06 (ddd, J ) 13.3, 4.2, 2.3 Hz, 1H), 1.74 (ddd, J
) 12.8, 4.1, 2.3 Hz, 1H), 1.42 (dd, J ) 13.3, 10.9 Hz, 1H), 1.37
(s, 3H), 1.4-1.3 (m, 1H), 1.27 (s, 3H), 1.09 (s, 3H), 0.88 (s, 9H),
0.06 (s, 6H) ppm; 13C NMR (100 MHz, CDCl3) δ 198.2 (s), 124.4
(s), 73.9 (d), 72.2 (s), 64.3 (d), 49.0 (t), 48.6 (t), 35.7 (s), 31.2 (q),
30.5 (q), 29.2 (q), 25.7 (q), 18.0 (s), -4.7 (q, 2×) ppm; MS (EI+)
m/z (%) 319 (M+ - tBu, 2), 317 (M+ - tBu, 2), 261 (19), 181
(100), 165 (91), 163 (21), 145 (38), 143 (17), 129 (20), 121 (33),
120 (16), 119 (21), 115 (28), 107 (28), 105 (70), 93 (44), 91 (24),
77 (16), 75 (97), 73 (58); HMRS (EI+) calcd for C13H2279BrO2Si
[M+ - tBu], 317.0572; found, 317.0577; IR (NaCl) ν 3600-3100
(br, OH), 2958 (s, C-H), 2929 (s, C-H), 2857 (m, C-H), 1950
(s, C-H), 2927 (s, C-H), 1939 (w, CdCdC); [R]22 +165.4 (c
D
0.02, MeOH).
(+)-(1S,3R,4aR)- and (+)-(1S,3R,4aS)-3-Hydroxy-4-[(E)-5-hy-
droxypenta-1,3-dienylidene]-3,5,5-trimethylcyclohexyl Acetate 10.
Following the general procedure for the cross-coupling reaction,
the reaction between iodoallene (aR)-2b (0.02 g, 0.06 mmol),
stannane 7 (0.03 g, 0.08 mmol), and PdCl2(PhCN)2 (0.002 g, 0.006
mmol) afforded, after purification by chromatography on silica gel
(60:40 hexane/EtOAc), 0.006 g (12%) of (1S,3R,4aR)-10 and 0.008
(28%) of (1S,3R,4aS)-10. Data for (1S,3R,4aR)-10: 1H NMR (400
MHz, CDCl3) δ 6.03 (ddt, J ) 15.1, 10.3, 1.3 Hz, 1H), 5.92 (d, J
) 10.3 Hz, 1H), 5.80 (dt, J ) 15.1, 5.8 Hz, 1H), 5.34 (tt, J ) 11.5,
4.2 Hz, 1H), 4.18 (dd, J ) 5.8, 1.0 Hz, 2H), 2.24 (ddd, J ) 12.8,
4.2, 2.2 Hz, 1H), 2.03 (s, 3H), 1.94 (ddd, J ) 12.5, 4.1, 2.2 Hz,
1H), 1.74 (s, 1H), 1.53 (s, 1H), 1.47 (dd, J ) 12.7, 11.6 Hz, 1H),
1.38 (t, J ) 12.0 Hz, 1H), 1.34 (s, 6H), 1.06 (s, 3H) ppm; 13C
NMR (100 MHz, CDCl3) δ 203.5 (s), 170.5 (s), 129.9 (d), 127.2
(d), 115.8 (s), 96.6 (d), 72.4 (s), 68.0 (d), 63.3 (t), 45.2 (t), 45.0
(t), 35.5 (s), 32.0 (q), 31.0 (q), 29.1 (q), 21.4 (q) ppm; MS (ESI+)
303 ([M + Na]+, 100); HRMS (ESI+) calcd for C16H24NaO4,
303.1567; found, 303.1564; IR (NaCl) ν 3600-3100 (br, OH), 2963
(w, CdCdC), 1470 (m), 1380 (m), 1256 (m, C-O), 1082 (s) cm-1
.
Anal. Calcd for C17H31BrO2Si: C, 54.39; H, 8.32. Found: C, 54.34;
H, 8.37. [R]22 -30.9 (c 0.04, CHCl3).
D
1
Data for (aS)-8a: H NMR (400 MHz, CDCl3) δ 6.10 (s, 1H),
4.23 (m, 1H), 2.07 (ddd, J ) 13.1, 3.9, 2.2 Hz, 1H), 1.74 (ddd, J
) 12.7, 4.1, 2.2 Hz, 1H), 1.36 (s, 2H), 1.3-1.2 (m, 3H), 1.31 (s,
3H), 1.07 (s, 3H), 0.86 (s, 9H), 0.06 (s, 6H) ppm; 13C NMR (100
MHz, CDCl3) δ 197.4 (s), 124.5 (s), 75.0 (d), 72.1 (s), 64.5 (d),
49.2 (t), 48.6 (t), 35.5 (s), 31.8 (q), 30.9 (q), 29.1 (q), 25.9 (q),
18.2 (s), -4.6 (q, 2×) ppm; MS (EI+) m/z (%) 376 (M+, 2), 374
(M+, 2), 295 (12), 263 (29), 261 (32), 260 (19), 181 (11), 145 (12),
105 (12), 75 (100), 73 (50); HMRS (EI+) calcd for C17H3179BrO2Si
[M+], 374.1277; found, 374.1279; IR (NaCl) ν 3600-3100 (br,
OH), 2958 (s, C-H), 2929 (s, C-H), 2856 (m, C-H), 1945 (w,
CdCdC), 1472 (m), 1384 (m), 1256 (m, C-O), 1081 (s) cm-1
;
[R]22 -45.4 (c 0.02, CHCl3).
(s, C-H), 2926 (s, C-H), 1939 (w, CdCdC); [R]22 +285.2 (c
D
D
General Procedure for the Cross-Coupling Reaction. The
palladium source [for PdCl2(PhCN)2, 0.1 or 0.2 mmol; for
Pd2(dba)3 ·CHCl3 and Pd(PPh3)4, 0.1 mmol; for Pd2(dba)3 and
AsPh3, 0.1 and 0.7 mmol, respectively] was added to a solution of
corresponding haloallene (1 mmol) and stannane (1.5 mmol) in
0.02, MeOH). Data for (1S,3R,4aS)-10: 1H NMR (400 MHz, CDCl3)
δ 6.09 (dd, J ) 15.0, 10.4 Hz, 1H), 6.01 (d, J ) 10.4 Hz, 1H),
5.80 (dt, J ) 15.0, 5.6 Hz, 1H), 5.33 (tt, J ) 11.5, 4.1 Hz, 1H),
4.18 (s, 2H), 2.21 (ddd, J ) 12.8, 4.1, 2.1 Hz, 1H), 2.02 (s, 3H),
1.91 (ddd, J ) 12.3, 4.0, 2.1 Hz, 1H), 1.44 (t, J ) 12.0 Hz, 1H),
J. Org. Chem. Vol. 73, No. 17, 2008 6539